Quick Answer
ANAVEX LIFE SCIENCES CORP. reported Cash and Equivalents of $102.58 million for fiscal year 2025.
ANAVEX LIFE SCIENCES CORP. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $102.58M | -22.4% |
| 2024 | $132.19M | -12.5% |
| 2023 | $151.02M | +1.3% |
| 2022 | $149.16M | -1.9% |
| 2021 | $152.11M | +420.0% |
| 2020 | $29.25M | +31.8% |
| 2019 | $22.19M | -3.2% |
| 2018 | $22.93M | -16.4% |
| 2017 | $27.44M | +198.7% |
| 2016 | $9.19M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $131.75M | +9.1% | +28.4% |
| September 30, 2025 | $102.58M | -22.4% | +1.4% |
| June 30, 2025 | $101.16M | -27.1% | -12.6% |
| March 31, 2025 | $115.77M | -16.9% | -4.1% |
| December 31, 2024 | $120.78M | -16.0% | -8.6% |
| September 30, 2024 | $132.19M | -12.5% | -4.7% |
| June 30, 2024 | $138.76M | -10.4% | -0.5% |
| March 31, 2024 | $139.39M | -9.2% | -3.0% |
- ANAVEX LIFE SCIENCES CORP. showed a decrease of -22.4% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2016–2025 period, ANAVEX LIFE SCIENCES CORP.’s cash and equivalents has grown by 1016.6% (from $9.19 million to $102.58 million).
- The most recent figure is from ANAVEX LIFE SCIENCES CORP.’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 25, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: